The PE Ratio as of December 2024 (TTM) for Ventyx Biosciences, Inc. (VTYX) is -1.00

According to Ventyx Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.00. This represents a change of -25.38% compared to the average of -1.34 of the last 4 quarters.

Ventyx Biosciences, Inc. (VTYX) Historical PE Ratio (quarterly & annually)

How has VTYX PE Ratio performed in the past?

The mean historical PE Ratio of Ventyx Biosciences, Inc. over the last ten years is -60.57. The current -1.00 PE Ratio has changed 65.08% with respect to the historical average. Over the past ten years (40 quarters), VTYX's PE Ratio was at its highest in in the December 2023 quarter at -0.78. The PE Ratio was at its lowest in in the September 2021 quarter at -19.45.

Ventyx Biosciences, Inc. (VTYX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ventyx Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ventyx Biosciences, Inc. (VTYX) Average PE Ratio

How has VTYX PE Ratio performed in the past?

The current PE Ratio of Ventyx Biosciences, Inc. (VTYX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ventyx Biosciences, Inc. (VTYX) PE Ratio vs. Peers

How is VTYX’s PE Ratio compared to its peers?

Ventyx Biosciences, Inc.’s PE Ratio is greater than Arcellx, Inc. (-102.24), greater than Immunocore Holdings plc (-26.20), greater than Vaxcyte, Inc. (-21.22), greater than DICE Therapeutics, Inc. (-22.94), greater than Nuvalent, Inc. (-24.55), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Travere Therapeutics, Inc. (-3.80), greater than Structure Therapeutics Inc. (-12.76), less than Replimune Group, Inc. (0), greater than Ascendis Pharma A/S (-4.55), greater than United Therapeutics Corporation (-17.93), less than IDEAYA Biosciences, Inc. (14.60), greater than Protagonist Therapeutics, Inc. (-12.28), less than Verona Pharma plc (14.68), greater than Syndax Pharmaceuticals, Inc. (-23.97), greater than null (-3.83),

Build a custom stock screener for Ventyx Biosciences, Inc. (VTYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ventyx Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ventyx Biosciences, Inc. (VTYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ventyx Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.